Baduanjin

Baduanjin for Blood Pressure: What a Yearlong Trial Found

A yearlong trial found a small but sustained blood pressure difference between baduanjin and self-directed exercise. The comparison with brisk walking needs careful reading.

Woman in a muted green outfit drawing a Baduanjin bow in a leafy garden

Baduanjin lowered average 24-hour systolic blood pressure by about 3 mm Hg more than self-directed exercise in a 2026 randomized trial. That difference appeared after 12 weeks and remained at one year. The practice also performed similarly to brisk walking in the trial, although a nonsignificant difference cannot prove the two are equal. For someone who enjoys slow, structured movement, this is useful evidence that the practice can be a reasonable way to work on blood pressure.

The BLESS trial (https://pubmed.ncbi.nlm.nih.gov/41706075/) is unusually helpful because it measured blood pressure throughout a full day, followed people for 52 weeks, and included both a general exercise comparison and a walking group. Its result is modest, and it applies most directly to adults with blood pressure near the lower end of the hypertension range. The trial did not test whether baduanjin prevented heart attacks or strokes.

What is baduanjin?

Baduanjin, sometimes called the Eight Brocades, is a sequence of eight gentle standing movements. It belongs to the broader family of qigong practices, which combine movement, posture, breathing, and focused attention. Movements typically involve lifting or extending the arms, turning the body, and shifting weight without the speed of an aerobic workout. The sequence can be taught in a group and then practiced at home. Our introduction to qigong explains the broader practice, but the blood pressure figures here come from the clinical trial.

The eight movements in order

The eight loops show each movement through a series of positions. Begin with soft knees and easy breathing. Our illustrated Baduanjin movement guide explains how to enter and leave every position, switch sides, and make the movements smaller when needed. The loops are teaching illustrations, not continuous recordings or individual instruction. The names below describe movement, not proven effects on individual organs.

1. Lift both hands toward the sky

Both arms rising overhead in the first Baduanjin movement

Raise both hands from the lower belly to a comfortable height overhead, then lower them slowly. Keep the ribs relaxed and do not lean back.

2. Draw the bow left and right

One arm extended sideways in the Baduanjin bow movement

With feet comfortably apart, extend one arm sideways and draw the other elbow back. Return to center and switch sides. Keep the knee bend shallow if needed.

3. Lift one hand and press the other down

One Baduanjin hand high and the other low

Reach one palm up while the other travels toward its hip. Return both hands to the middle, then reverse them without tilting the trunk.

4. Look behind each shoulder

Head turning gently in the fourth Baduanjin movement

Turn the head slowly to look over one shoulder, return to center, and repeat on the other side. Keep the turn small and comfortable.

5. Sway the head and tail

Torso leaning gently to one side in a wide stance

Place hands on the thighs in a shallow wide stance. Move the trunk in a small, slow arc from one side through the front to the other, then reverse.

6. Reach toward the feet

Torso bending at the hips in the sixth Baduanjin movement

Hinge at the hips and slide the hands toward the thighs, shins, or feet. Rise slowly. Touching the toes is optional.

7. Extend one fist with a steady gaze

One arm extending slowly from the waist

From a comfortable wide stance, extend one loose fist, bring it back, and alternate arms. Avoid snapping the elbow straight.

8. Rise gently on the toes

Heels raised in the final Baduanjin movement

Lift both heels a little, pause, and lower them quietly. Use a stable support if balance is uncertain.

Who joined the yearlong study?

Researchers enrolled 216 adults from seven communities in China. Participants were at least 40 years old, and their qualifying blood pressure was in a narrow band: systolic pressure of 130 to 139 mm Hg and/or diastolic pressure of 85 to 89 mm Hg. Systolic is the top number on a blood pressure reading. The mean age was 57.3 years, and nearly two-thirds of participants were women. The BLESS trial record (https://pubmed.ncbi.nlm.nih.gov/41706075/) describes a multicenter, randomized study, meaning the comparison was made across several communities and group assignment was determined by chance.

The researchers assigned 108 people to baduanjin, 54 to self-directed exercise alone, and 54 to brisk walking. The uneven numbers were intentional. The intervention continued for 52 weeks. People knew which activity they were doing, as they would in almost any exercise study, while outcome assessment was blinded. That combination makes the blood pressure measurement more persuasive than an unblinded report of how healthy participants felt.

These participants were not a sample of everyone with hypertension. Their readings sat in a specific range, and they were recruited in Chinese communities where baduanjin is culturally familiar. The result may differ in people with substantially higher pressure, frailty, pregnancy, or medical conditions that affect exercise. The paper does not establish a safe or effective dose for every reader.

What did the researchers measure?

The two main outcomes were changes in average systolic pressure over 24 hours at week 12 and week 52. A wearable monitor takes repeated readings as someone goes through daytime activities and sleep. This reduces the chance that a single reading in a clinic will dominate the result. Blood pressure still varies from day to day, so a group average is more informative than any one person's change.

The trial tested its comparisons in a set order. It first asked whether baduanjin beat self-directed exercise at 12 weeks, then at 52 weeks. Only after those tests did it assess whether baduanjin beat brisk walking at one year. This ordering, reported in the BLESS paper (https://pubmed.ncbi.nlm.nih.gov/41706075/), matters because testing many outcomes without a plan can produce chance findings. The reported primary outcome was a measured risk marker. It was not a count of strokes, heart attacks, medication changes, or deaths.

The publication calls the participants' range high-normal blood pressure. Classification differs by country and guideline. Under the American Heart Association's current categories, a systolic reading of 130 to 139 mm Hg falls in stage 1 hypertension (https://professional.heart.org/en/science-news/2025-high-blood-pressure-guideline/top-things-to-know). Readers should use their own clinician's interpretation of repeated readings rather than assume that a label from a Chinese trial maps exactly onto their situation.

How much did blood pressure change?

At 12 weeks, the baduanjin group's average 24-hour systolic pressure had fallen 3.1 mm Hg more than the self-directed exercise group's, after adjustment in the trial analysis. The 95% confidence interval for that difference ran from a 5.9 mm Hg greater reduction to a 0.2 mm Hg greater reduction. At one year, the difference was 3.3 mm Hg in favor of baduanjin, with a confidence interval from 6.3 to 0.3 mm Hg. Both intervals narrowly excluded no difference. These are the trial's between-group results (https://pubmed.ncbi.nlm.nih.gov/41706075/), not the total amount by which an individual should expect a home reading to fall.

The brisk walking comparison is easy to overstate. At 52 weeks, the estimated difference between baduanjin and walking was 0.7 mm Hg in favor of baduanjin, but the confidence interval stretched from 3.9 mm Hg in favor of baduanjin to 2.6 mm Hg in favor of walking. The statistical test found no clear winner. That supports saying the two groups had similar results in this sample. It does not show that one routine can replace all the physical benefits of walking, or that the two would stay equivalent in a much larger trial.

The researchers reported no significant difference in adverse events among the three groups. This is reassuring within the study, but 216 participants are too few to rule out uncommon problems. The PubMed abstract does not provide a detailed breakdown of events or adherence. Full text access was restricted during this review, so those details need checking before publication.

Why does a few points matter, and what remains unknown?

A small shift in average blood pressure may be worthwhile across a population. For one person, however, a 3 mm Hg group difference can be hard to distinguish from normal day-to-day variation without repeated, careful measurement. The trial shows an effect on a cardiovascular risk marker. It cannot tell us how many participants avoided a future stroke or whether any person could safely stop medicine. Those outcomes require different studies and longer follow-up.

The design has several strengths. Random assignment reduces the chance that baseline differences explain the result. Seven recruitment communities make the finding less dependent on one instructor or clinic. A 24-hour monitor offers a better look at daily pressure than an isolated office reading. A one-year follow-up addresses the common problem of short exercise trials that show an early change and then stop.

There are limits too. Neither participants nor instructors could be blinded to a movement practice, and expectations can change how consistently people exercise or follow other habits. The self-directed exercise group may not have received the same attention or structure as the baduanjin group. The study therefore tests a complete practice and delivery approach, not a special property of eight movements isolated from instruction, routine, and motivation. The publication's abstract reports no individual adherence figures, so we cannot tell from that record how much practice was needed for the observed average result.

Does earlier research point the same way?

An earlier randomized trial in 170 older community adults at risk of ischemic stroke tested supervised baduanjin for 12 weeks against keeping usual habits. The Zheng trial (https://pubmed.ncbi.nlm.nih.gov/30718622/) found lower systolic and diastolic pressure in the baduanjin group, alongside changes in several other measured outcomes. Participants did five 60-minute sessions each week, a much larger time commitment than a brief home routine. Because the trial measured many outcomes and used a usual-habits comparison, it should support the direction of the BLESS result without supplying a single universal estimate of benefit.

A 2025 randomized trial (https://pubmed.ncbi.nlm.nih.gov/40582060/) studied only 40 older women with mild subclinical hypothyroidism and mild cognitive impairment. Both groups received levothyroxine; one also practiced Baduanjin for 12 weeks. The abstract reports larger improvements in blood pressure and several other measures with added exercise. Its small, highly selected sample and multiple outcomes make it less useful than BLESS for estimating what a general reader's blood pressure might do. It does not show that Baduanjin treats thyroid disease or replaces medication.

What can a reader do with this evidence?

Baduanjin is worth considering if you have mildly raised blood pressure and prefer a gentle, repeatable practice. A class or qualified instructor can help you learn the sequence, find a pace that feels steady, and adapt movements that strain a joint. Start within your present ability. The trial tested a sustained program, so one short session should not be expected to move a blood pressure reading. The Healthy Mango article on a small Monday blood pressure study is a reminder that a single reading can mislead; it is background on measurement, not evidence for baduanjin.

Use a validated upper-arm monitor if you follow blood pressure at home. The American Heart Association's measurement instructions (https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home) advise sitting quietly, supporting the arm at heart level, and taking two readings one minute apart each time. Record readings across days and review the pattern with a clinician. That is more useful than checking immediately after a session and crediting the practice for one low number.

Qigong is generally considered a safe form of activity when performed appropriately, but sore muscles, dizziness, and balance problems can still matter. The National Center for Complementary and Integrative Health overview (https://www.nccih.nih.gov/health/qigong-what-you-need-to-know) notes that people with health conditions may need to modify physical practices. If exercise causes chest pain, faintness, severe breathlessness, or a new neurological symptom, stop and seek medical assessment. People taking blood pressure medicine should keep taking it as directed unless their clinician changes the plan after reviewing reliable measurements.

The practical reading of the 2026 result is straightforward: baduanjin produced a small, sustained improvement in 24-hour systolic pressure against self-directed exercise in adults with a specific blood pressure range. It offers another way to move regularly for people who will actually enjoy and continue it. The trial leaves room for choice between this practice and walking, and it leaves open whether the blood pressure change translates into fewer cardiovascular events.

Join the conversation

Your thoughts are welcome.

Share a question or your experience. Sign in with GitHub to comment. Comments are public—please keep personal health details private.